What type of study is this?

This is a Cohort Study study (also classified as: Validation Study).

December 5, 2025Frontiers in ImmunologyOpen Access

LASSO-empowered nomogram integrating nutritional-inflammatory-tumor characteristics predicts immunotherapy outcomes in advanced HCC: Large retrospective cohort

View Full Paper

Ask AI

Bookmark

The nomogram predicts immunotherapy outcomes in advanced HCC patients, revealing critical risk factors that influence treatment efficacy.
The model demonstrated AUC values exceeding 0.75 for overall survival at multiple time points, confirming its robust discriminatory power.
Analysis utilized retrospective data from 537 advanced HCC patients treated with immune checkpoint inhibitors, optimizing prognostic accuracy.
The tool integrates nutritional, inflammatory, and tumor characteristics, suggesting personalized therapeutic strategies for better management in clinical settings.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective analysis finds a prognostic model enhances overall survival prediction in advanced HCC, indicating significant implications for immunotherapy strategies.

Cite This Study

Shuifang Hu (2025) studied this question.

synapsesocial.com/papers/693231118e51979591dce02f https://doi.org/10.3389/fimmu.2025.1626940

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis finds a prognostic model enhances overall survival prediction in advanced HCC, indicating significant implications for immunotherapy strategies.

LASSO-empowered nomogram integrating nutritional-inflammatory-tumor characteristics predicts immunotherapy outcomes in advanced HCC: Large retrospective cohort

Key Points

Discussion

Implication

Cite This Study

LASSO-empowered nomogram integrating nutritional-inflammatory-tumor characteristics predicts immunotherapy outcomes in advanced HCC: Large retrospective cohort

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading